XML 45 R32.htm IDEA: XBRL DOCUMENT v3.20.2
Segments (Tables)
 6 Months Ended
Jun. 30, 2020
Segment Reporting [Abstract]  
Operations and Assets for Operating Segments and Geographic Information Information regarding our operations and assets for our operating segments and the unallocated corporate operations as well as geographic information are as follows:
 For the three months ended June 30,For the six months ended June 30,
(In thousands)2020201920202019
Revenue from services:
Pharmaceutical$—  $—  $—  $—  
Diagnostics250,971  178,458  421,811  357,349  
Corporate—  —  —  —  
$250,971  $178,458  $421,811  $357,349  
Revenue from products:
Pharmaceutical$29,356  $28,680  $60,430  $53,981  
Diagnostics—  —  —  —  
Corporate—  —  —  —  
$29,356  $28,680  $60,430  $53,981  
Revenue from transfer of intellectual property and other:
Pharmaceutical$14,686  $19,230  $24,239  $37,490  
Diagnostics6,194  —  6,194  —  
Corporate—  —  —  —  
$20,880  $19,230  $30,433  $37,490  
Operating loss:
Pharmaceutical$(5,996) $(8,556) $(20,121) $(38,033) 
Diagnostics40,935  (28,013) 22,803  (61,582) 
Corporate(7,760) (10,691) (16,263) (22,962) 
$27,179  $(47,260) $(13,581) $(122,577) 
Depreciation and amortization:
Pharmaceutical$7,119  $7,382  $14,240  $14,908  
Diagnostics15,147  16,260  30,019  32,530  
Corporate—  19  59  39  
$22,266  $23,661  $44,318  $47,477  
Loss from investment in investees:
Pharmaceutical$(189) $(271) $(323) $(2,125) 
Diagnostics—  —  —  —  
Corporate—  —  —  —  
$(189) $(271) $(323) $(2,125) 
Revenues:
United States$265,890  $184,310  $446,761  $369,203  
Ireland16,847  22,174  28,749  42,707  
Chile11,152  9,051  22,002  16,915  
Spain4,136  4,876  8,292  9,294  
Israel1,183  3,768  2,890  6,884  
Mexico1,866  2,058  3,708  3,589  
Other133  131  272  228  
$301,207  $226,368  $512,674  $448,820  
(In thousands)June 30,
2020		December 31,
2019
Assets:
Pharmaceutical$1,148,151  $1,174,639  
Diagnostics1,121,202  1,035,112  
Corporate54,381  99,521  
$2,323,734  $2,309,272  
Goodwill:
Pharmaceutical$236,790  $237,131  
Diagnostics434,809  434,809  
Corporate—  —  
$671,599  $671,940